Kidney Cancer

Latest News

Subcutaneous nivolumab under review in EU for solid tumors
Subcutaneous nivolumab under review in EU for solid tumors

March 31st 2025

The European Commission must issue a decision on the application on or by June 2, 2025.

Sintilimab/fruquintinib combo meets primary PFS end point in advanced RCC
Sintilimab/fruquintinib combo meets primary PFS end point in advanced RCC

March 19th 2025

FDA greenlights trial of orellanine in metastatic renal cell carcinoma
FDA greenlights trial of orellanine in metastatic renal cell carcinoma

March 18th 2025

Identifying unique therapeutic targets for chromophobe kidney cancer
Identifying unique therapeutic targets for chromophobe kidney cancer

March 6th 2025

FDA updates in urology: February 2025
FDA updates in urology: February 2025

March 3rd 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.